Search results

ANSTO’s Innovation Precinct welcomes NSW Government’s $12.5 commitment funding.

Bushfires in proximity to ANSTO during the 2018 bushfires.

Australia’s new state-of-the-art nuclear medicine facility gets green light.

Do you love science? Here is a competition for you that combines chemistry and creativity! Discover the world of elements and create a poster for your favourite element in this new competition for school aged students.

See details of previously published customer updates from our Health products team. 

Planning is now underway for a second repatriation project which is scheduled to take place in 2022. Find out more information.

ANSTO to receive a new grant to continue to fight chronic kidney disease killer in Sri Lanka.

The Biological Small Angle X-ray Scattering beamline will be optimised for measuring small angle scattering of surfactants, nanoparticles, polymers, lipids, proteins and other biological macromolecules in solution. BioSAXS combines combine a state-of-the-art high-flux small angle scattering beamline with specialised in-line protein purification and preparation techniques for high-throughput protein analysis.

This afternoon, the Chair of ANSTO, Dr Annabelle Bennett, wrote to all staff to let them know that CEO Dr Adi Paterson has decided to resign. She said the Board is deeply appreciative of the contributions Adi has made, including to the health, research and academic outputs of ANSTO during his tenure. Mr Shaun Jenkinson will continue as Acting CEO, while the Board undertakes a global search for a permanent CEO.

ANSTO seeks candidates who are passionate about making a contribution to Australian society through supporting nuclear science and technology.

On the 9th of December 2022, the Minister for Industry, Science and Technology provided his Statement of Expectations to ANSTO.